“…Additional case studies or case series performed outside the clinical trial setting also reported ATII response in distributive shock associated with cirrhosis, postcardiopulmonary bypass, liver transplant, near drowning, and COVID-19, providing further limited evidence for ATII efficacy (31–36).…”